Curtin N J, Harris A L, Aherne G W
Cancer Research Unit, Medical School, University of Newcastle upon Tyne, England.
Cancer Res. 1991 May 1;51(9):2346-52.
The thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) inhibits the growth of human lung carcinoma A549 cells. The cytotoxicity of CB3717 is potentiated by the nucleoside transport inhibitor dipyridamole (DP), which not only inhibits the uptake and therefore salvage of thymidine but also inhibits the efflux of deoxyuridine, thereby enhancing the intracellular accumulation of deoxyuridine nucleotides. Measurement of intracellular deoxyuridine triphosphate (dUTP) pools, by sensitive radioimmunoassay, demonstrated a large increase in response to CB3717, in a dose- and time-related manner, and this accumulation was enhanced by coincubation with DP. In untreated cells and those treated with DP alone, dUTP was close to or below the limit of detection of the assay. In cells treated for 24 h with 3 microM CB3717 (concentration producing 50% growth inhibition) the intracellular dUTP was 46.1 +/- 9.6 (SEM) pmol/10(6) cells and after 24 h exposure to 30 microM CB3717, 337.5 +/- 37.9 pmol dUTP/10(6) cells was detected. There was significant enhancement by DP of the accumulation of dUTP in cells treated with CB3717; coincubation of cells with 1 microM DP + 3 microM CB3717 for 24 h resulted in intracellular dUTP levels of 174.7 +/- 57.7 pmol/10(6) cells. Accumulation of DNA strand breaks, measured by alkaline elution, also increased in response to CB3717 concentration and exposure period. Newly synthesized (nascent) DNA was more sensitive to damage by CB3717 than was mature DNA. As with the accumulation of dUTP, coincubation with DP also enhanced the accumulation of strand breaks, whereas DP alone had little or no effect on DNA fragmentation. When data for cells treated with CB3717 alone and CB3717 in combination with DP were combined, there was a significant correlation of intracellular dUTP levels with the level of DNA strand breaks. This strongly suggests that growth inhibition following thymidylate synthase inhibition is mediated through an increase in intracellular dUTP, leading to uracil misincorporation into DNA, its subsequent excision, and resultant strand breakage.
胸苷酸合成酶抑制剂N10-炔丙基-5,8-二氮杂叶酸(CB3717)可抑制人肺癌A549细胞的生长。核苷转运抑制剂双嘧达莫(DP)可增强CB3717的细胞毒性,它不仅抑制胸苷的摄取及因此而来的补救合成,还抑制脱氧尿苷的外排,从而增加细胞内脱氧尿苷核苷酸的蓄积。通过灵敏的放射免疫测定法检测细胞内三磷酸脱氧尿苷(dUTP)库,结果表明,dUTP库对CB3717呈剂量和时间依赖性大幅增加,并且与DP共同孵育可增强这种蓄积。在未处理的细胞及仅用DP处理的细胞中,dUTP接近或低于该测定法的检测限。在用3μM CB3717(产生50%生长抑制的浓度)处理24小时的细胞中,细胞内dUTP为46.1±9.6(标准误)pmol/10⁶个细胞,在暴露于30μM CB3717 24小时后,检测到337.5±37.9 pmol dUTP/10⁶个细胞。DP可显著增强CB3717处理的细胞中dUTP的蓄积;细胞与1μM DP + 3μM CB3717共同孵育24小时导致细胞内dUTP水平达到174.7±57.7 pmol/10⁶个细胞。通过碱性洗脱法测定的DNA链断裂的蓄积也随CB3717浓度和暴露时间的增加而增加。新合成的(新生)DNA比成熟DNA对CB3717的损伤更敏感。与dUTP的蓄积情况一样,与DP共同孵育也增强了链断裂的蓄积,而单独使用DP对DNA片段化几乎没有影响。当将单独用CB3717处理的细胞及CB3717与DP联合处理的细胞的数据合并时,细胞内dUTP水平与DNA链断裂水平之间存在显著相关性。这强烈表明,胸苷酸合成酶抑制后的生长抑制是通过细胞内dUTP增加介导的,导致尿嘧啶错误掺入DNA,随后被切除,从而产生链断裂。